Avicef S (1000+500) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Admac Pharma Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Cefotaxime, Sulbactam. This drug comes in the form of Injection. The general packing available for this medicine consists of 1 Vial and is priced at Rs 47.25 (arround $0.6615 US Dollar)
Generic (Salt) Combination :
(Cefotaxime+ Sulbactam)
Pharma Company :
Admac Pharma Ltd.
Brand Label :
Avicef S (1000+500)
Preparation Type :
Injection
Single Dose :
1 Vial
Composition (Fixed-Dose Combination) :
Sulbactam-500 mg
Cefotaxime-1000 mg
Pack Size/Qty/Vol :
1 Vial
Price Unit :
Rs 47.25 INR (arround $0.6615 US Dollar)
Price Pack :
Rs 47.25 INR (arround $0.6615 US Dollar)
Drug details for Avicef S (1000+500)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Avicef S (1000+500) are :
Sulbactam-500 mg
Cefotaxime-1000 mg
Cefotaxime Indication (Prescribed for or used as): Respiratory, urinary, bone, soft tissue infections. Gonorrhoea. Meningitis.
For more details on Cefotaxime, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Cefotaxime..
Sulbactam Indication (Prescribed for or used as): Gonorrhoea. Mixed aerobic-anaerobic infections. Infections especially those acquired in the hospital.
For more details on Sulbactam, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Sulbactam..
Avicef S (1000+500) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 10 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Avicef S (1000+500), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Sulbactam-500 mg Cefotaxime-1000 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.